<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7073332\results\search\testTrace\results.xml">
  <result pre="an urgent need for the development of effective prevention and" exact="treatment" post="strategies for 2019-nCoV/SARS-CoV-2 outbreak. Although investment in biomedical and"/>
  <result pre="PPIs), and can serve as a useful tool for efficient" exact="screening" post="of potentially new indications for approved drugs, as well"/>
  <result pre="notions that (i) the proteins that functionally associate with viral" exact="infection" post="(including HCoV) are localized in the corresponding subnetwork within"/>
  <result pre="disease may also be suitable drug targets for potential antiviral" exact="infection" post="owing to common PPIs and functional pathways elucidated by"/>
  <result pre="disease may also be suitable drug targets for potential antiviral" exact="infection" post="owing to common proteinâ€&quot;protein interactions elucidated by the human"/>
  <result pre="transmembrane glycoprotein that plays a pivotal role in mediating viral" exact="infection" post="through binding the host receptor31,32. Figure 2d shows the"/>
  <result pre="by specifically targeting cellular proteins associated with HCoVs for potential" exact="treatment" post="of 2019-nCoV/SARS-CoV-2. Fig. 3 Drug-target network analysis of the"/>
  <result pre="that the proteins that associate with and functionally govern viral" exact="infection" post="are localized in the corresponding subnetwork (Fig. 1a) within"/>
  <result pre="(Zâ€‰=â€‰â€&quot;5.98), a typical ARB, was approved by the FDA for" exact="treatment" post="of hypertension and diabetic nephropathy. Here, network proximity analysis"/>
  <result pre="the latest study revealed the clinical application: sirolimus reduced MERS-CoV" exact="infection" post="by over 60%51. Moreover, sirolimus usage in managing patients"/>
  <result pre="drugs that target diverse cellular pathways for potential prevention and" exact="treatment" post="of 2019-nCoV/SARS-CoV-2. However, further preclinical experiments64 and clinical trials"/>
  <result pre="and antineoplastic properties) plus dactinomycin (an RNA synthesis inhibitor for" exact="treatment" post="of various tumors), c toremifene (first-generation nonsteroidal-selective estrogen receptor"/>
  <result pre="estrogen receptor modulator) plus emodin (an experimental drug for the" exact="treatment" post="of polycystic kidney), and d melatonin (a biogenic amine"/>
  <result pre="known actinomycin D, is an approved RNA synthesis inhibitor for" exact="treatment" post="of various cancer types. An early study showed that"/>
  <result pre="subnetwork by â€œComplementary Exposureâ€� pattern, offering potential combination regimens for" exact="treatment" post="of HCoV. Specifically, sirolimus and dactinomycin may inhibit both"/>
  <result pre="Toremifene is among the approved first-generation nonsteroidal SERMs for the" exact="treatment" post="of metastatic breast cancer68. SERMs (including toremifene) inhibited Ebola"/>
  <result pre="by targeting papain-like protease53,54. Melatonin was reported in potential antiviral" exact="infection" post="via its anti-inflammatory and antioxidant effects58â€&quot;62. Melatonin indirectly regulates"/>
  <result pre="regulates ACE2 expression, a key entry receptor involved in viral" exact="infection" post="of HCoVs, including 2019-nCoV/SARS-CoV-2 (ref. 33). Specifically, melatonin was"/>
  <result pre="identification of putative repurposable drugs and drug combinations for potential" exact="treatment" post="of 2019-nCoV/SARS-CoV-2. Integration of drugâ€&quot;target networks, HCoVâ€&quot;host interactions, HCoV-induced"/>
  <result pre="identification of repurposable drugs and drug combinations for the potential" exact="treatment" post="of 2019-nCoV/SARS-CoV-2. Our approach can minimize the translational gap"/>
  <result pre="2019-nCoV/SARS-CoV-2. Our approach can minimize the translational gap between preclinical" exact="testing" post="results and clinical outcomes, which is a significant problem"/>
  <result pre="is a significant problem in the rapid development of efficient" exact="treatment" post="strategies for the emerging 2019-nCoV/SARS-CoV-2 outbreak. From a translational"/>
  <result pre="applied, the network tools developed here could help develop effective" exact="treatment" post="strategies for other emerging viral infections and other human"/>
  <result pre="HCoV proteins or were involved in critical pathways of HCoV" exact="infection" post="identified by multiple experimental sources, including high-throughput yeast-two-hybrid (Y2H)"/>
  <result pre="provide an unbiased, rational roadmap for repurposing drugs for potential" exact="treatment" post="of HCoVs in which they were not originally approved."/>
  <result pre="data sets were used as HCoVâ€&quot;host signatures to evaluate the" exact="treatment" post="effects of drugs. Differential gene expression in cells treated"/>
  <result pre="of the ES scores. Drugs were considered to have potential" exact="treatment" post="effect if ESâ€‰&amp;gt;â€‰0 and Pâ€‰ Supplementary information LINK Supplementary"/>
  <result pre="and applicationsPhysics Reports202084616610.1016/j.physrep.2019.12.004 17.DyallJet al.Repurposing of clinically developed drugs for" exact="treatment" post="of Middle East respiratory syndrome coronavirus infectionAntimicrob. Agents Chemother.2014584885489310.1128/AAC.03036-1424841273"/>
  <result pre="19.HeSet al.Repurposing of the antihistamine chlorcyclizine and related compounds for" exact="treatment" post="of hepatitis C virus infectionSci. Transl. Med.20157282ra24910.1126/scitranslmed.3010286 20.BarrowsNJet al.A"/>
  <result pre="Host. Microbe20162025927010.1016/j.chom.2016.07.00427476412 21.XuMet al.Identification of small-molecule inhibitors of Zika virus" exact="infection" post="and induced neural cell death via a drug repurposing"/>
  <result pre="cell mTORC1 is required for HCV RNA replicationGut2016652017202810.1136/gutjnl-2014-30897126276683 50.WangCHet al.Adjuvant" exact="treatment" post="with a mammalian target of rapamycin inhibitor, sirolimus, and"/>
  <result pre="and PI3K/AKT/mTOR signaling modulation for Middle East respiratory syndrome coronavirus" exact="infection" post="as identified by temporal kinome analysisAntimicrob. Agents Chemother.2015591088109910.1128/AAC.03659-1425487801 67.LewisELHarbourDABeringerJEGrinstedJDifferential"/>
  <result pre="Arch. Pharmacol.201638969571210.1007/s00210-016-1252-427146293 79.LiQet al.Integrative functional genomics of hepatitis C virus" exact="infection" post="identifies host dependencies in complete viral replication cyclePLoS Pathog.201410e100416310.1371/journal.ppat.100416324852294"/>
  <result pre="severe acute respiratory syndromeBMC Immunol.20056210.1186/1471-2172-6-215655079 95.JossetLet al.Cell host response to" exact="infection" post="with novel human coronavirus EMC predicts potential antivirals and"/>
 </snippets>
</snippetsTree>
